Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FRDJ4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,944
Award facts
- Contract value 100% obligated
- $15,944.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $15,944.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. The award, issued on December 18, 2025, with an ultimate completion date of January 12, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, having maintained registration in the System for Award Management since 2001 and demonstrating substantial contracting activity with the Defense Logistics Agency. The company's comprehensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning it to fulfill the diverse pharmaceutical requirements of military healthcare operations globally. The Mirena contraceptive system delivery under this order exemplifies the company's role in supporting routine medical supply needs across Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FRDJ4?
SPE2DR26FRDJ4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FRDJ4 worth?
The government has obligated $15,944 on SPE2DR26FRDJ4.
Is contract SPE2DR26FRDJ4 an order under another contract?
Yes. SPE2DR26FRDJ4 is a delivery order under SPE2DR25D9143, an indefinite delivery contract.
Was contract SPE2DR26FRDJ4 competed?
The extent of competition for SPE2DR26FRDJ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award